Abstract
New lactose–2-iminothiazolidin-4-one hybrids 7a–h had the multi-target inhibitions for T2DM enzymes. They showed high anti-glycation, antioxidant activities and no-cytotoxic for WI-38 cell. Molecular docking and dynamics studies were applied.

This publication has 53 references indexed in Scilit: